$PBLS SEC Filings

Filed On	Filing
15 Sep 2026	8-K: Regulation FD Disclosure Parabilis Medicines, Inc. is updating its guidance to reflect its intention to present updated clinical data from the ongoing Phase 1/2 study of zolucatetide in desmoid tumor patients in an oral presentation at the European Society for M...
02 Sep 2026	8-K: Departure/Election of Directors or Officers; Compensation
25 Aug 2026	Form 4: Tendler Craig, Director Granted 20,294 Stock Option (Right to Buy)
25 Aug 2026	Form 3: Tendler Craig, Director
25 Aug 2026	8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure
14 Aug 2026	SCHEDULE 13G
13 Aug 2026	10-Q
13 Aug 2026	8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
06 Aug 2026	SCHEDULE 13G
22 Jul 2026	Form 4: Ra Capital MANAGEMENT, L.p., Director and 4 others Bought 131,420 shares ($3.58M) · Bought 65,923 shares ($1.93M) · Bought 47,250 shares ($1.41M)
29 Jun 2026	Form 4: Levy Guy, 10% owner and 8 others Bought 500,000 shares ($10M) · Received 527,070 shares by conversion ($5M)
29 Jun 2026	Form 3: Levy Guy, 10% owner and 5 others
18 Jun 2026	SCHEDULE 13D
16 Jun 2026	Form 4: Sebulsky Alan, Director Bought 8,435 shares ($233K) · Bought 9,065 shares ($240K)
15 Jun 2026	Form 4: Ra Capital MANAGEMENT, L.p., Director and 4 others Received 7,744,621 shares by conversion · Bought 21,188,750 shares ($424M)
15 Jun 2026	Form 4: Fitzgerald Edward M, Director Received 14,688 shares by conversion · Acquired 5,332 Series B Preferred Stock (Derivative Conversion) · Acquired 3,666 Series C Preferred Stock (Derivative Conversion) · 1 more
15 Jun 2026	Form 4: Sebulsky Alan, Director Bought 12,500 shares ($250K)
15 Jun 2026	Form 4: Borisy Alexis, Director Received 105,414 shares by conversion · Acquired 162,221 Series F Preferred Stock (Derivative Conversion)
11 Jun 2026	Form 4: Flynn James E, 10% owner and 5 others Received 1,880,704 shares by conversion
11 Jun 2026	Form 4: Ra Capital MANAGEMENT, L.p., Director and 4 others Granted 20,215 Stock Option (Right to Buy)

Comments